What development phase is Cadral in?

Cadral is FDA-approved (marketed).

What is the generic name of Cadral?

CADRALAZINE is the generic (nonproprietary) name of Cadral.

Last reviewed 2026-04-20 · How we verify

Cadral (CADRALAZINE)

FDA-approved active Small molecule Quality 10/100

At a glance

Generic name	CADRALAZINE
Drug class	cadralazine
Target	Myeloperoxidase, Voltage-dependent L-type calcium channel subunit alpha-1C
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cadral CI brief — competitive landscape report
Cadral updates RSS · CI watch RSS